Detection of higher levels of dengue viremia using FcγR-expressing BHK-21 cells than FcγR-negative cells in secondary infection but not in primary infection

Journal of Infectious Diseases

Volumn 203, Issue 10, 2011, Pages 1405-1414

  Moi, Meng Ling ^a   Lim, Chang Kweng ^a   Kotaki, Akira ^a   Takasaki, Tomohiko ^a   Kurane, Ichiro ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; FC RECEPTOR IIA; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; ANTIGEN EXPRESSION; ARTICLE; CELL LINE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DENGUE VIRUS 4; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NONHUMAN; PRIMARY INFECTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECONDARY INFECTION; SEROLOGY; SEROTYPE; SUPERNATANT; VIRAL CLEARANCE; VIRUS TITRATION;

ADOLESCENT; ADULT; ANIMALS; ANTIGEN-ANTIBODY COMPLEX; CELL LINE; CRICETINAE; DENGUE; DENGUE VIRUS; FEMALE; HUMANS; MALE; MIDDLE AGED; PLAQUE ASSAY; RECEPTORS, IGG; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VIREMIA; YOUNG ADULT;

EID: 79955046952     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir053     Document Type: Article

References (24)

1. Kontny U, Kurane I, Ennis FA. Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells. J Virol 1988; 62:3928-33.
2. Littaua R, Kurane I, Ennis FA. Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J Immunol 1990; 144:3183-6. (Pubitemid 20149498)
3. Libraty DH, Endy TP, Houng HS, et al. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis 2002; 185:1213-21. (Pubitemid 34439127)
4. Vaughn DW, Green S, Kalayanarooj S, et al. Dengue in the early febrile phase: Viremia and antibody responses. J Infect Dis 1997; 176:322-30. (Pubitemid 27328753)
5. Vaughn DW, Green S, Kalayanarooj S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000; 181:2-9. (Pubitemid 30049026)
6. Bae HG, Nitsche A, Teichmann A, Biel SS, Niedrig M. Detection of yellow fever virus: A comparison of quantitative real-time PCR and plaque assay. J Virol Meth 2003; 110:185-91. (Pubitemid 36645263)
7. Daëron M. Fc receptor biology. Annu Rev Immunol 1997; 15:203-34. (Pubitemid 27169280)
8. Morens DM, Halstead SB, Repik PM, Putvana R, Raybourne N. Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: Comparison of the BHK suspension test with standard plaque reduction neutralization. J Clin Microbiol 1985; 22:250-4. (Pubitemid 15006964)
9. Roehrig JT. Guidelines for plaque reduction neutralization testing of human antibodies to dengue viruses. Geneva, Switzerland: World Health Organization, 2007.
10. Ruangjirachuporn W, Boonpucknavig S, Nimmanitya S. Circulating immune complexes in serum from patients with dengue haemorrhagic fever. Clin Exp Immunol 1979; 36:46-53. (Pubitemid 9147656)
11. Wang WK, Chen HL, Yang CF, et al. Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. Clin Infect Dis 2006; 43:1023-30.
12. Yamada K, Takasaki T, Nawa M, Kurane I. Virus isolation as one of the diagnostic methods for dengue virus infection. J Clin Virol 1999; 24:203-9.
13. Ito M, Takasaki T, Yamada K, et al. Development and evaluation of fluorogenic TaqMan reverse transcriptase PCR assays for detection of dengue virus types 1 to 4. J Clin Microbiol 2004; 42:5935-5937. (Pubitemid 39664400)
14. Vaughn DW, Nisalak A, Kalayanarooj S, et al. Evaluation of a rapid immunochromatographic test for diagnosis of dengue virus infection. J Clin Microbiol 1998; 36:234-8. (Pubitemid 28047466)
15. World Health Organization 2009. Dengue guidelines for diagnosis, treatment, prevention and control. http://whqlibdoc.who.int/ publications/2009/9789241547871-eng.pdf. Accessed 17 December 2010.
16. Moi ML, Lim CK, Kotaki A, Takasaki T, Kurane I. Development of an antibody-dependent enhancement assay for dengue virus using stable BHK-21 cell lines expressing FccRIIA. J Virol Meth 2010; 163:205-9.
17. Moi ML, Lim CK, Kotaki A, Takasaki T, Kurane I. Discrepancy in dengue virus neutralizing antibody titers between plaque reduction neutralizing tests with Fcc receptor (FccR)-negative and FccR-expressing BHK-21 cells. Clin Vaccine Immunol 2010; 17:402-7.
18. Pilling D, Tucker NM, Gomer RH. Aggregated IgG inhibits the differentiation of human fibrocytes. J Leukoc Biol 2006; 79:1242-51. (Pubitemid 44835558)
19. Guilarde AO, Turchi MD, Siqueira JB, et al. Dengue and dengue hemorrhagic fever among adults: Clinical outcomes related to viremia, serotypes and antibody response. J Infect Dis 2008; 197:817-24. (Pubitemid 351417004)
20. Gubler DJ, Suharyono W, Tan R, Abidin M, Sie A. Viraemia in patients with naturally acquired dengue infection. Bull World Health Organ 1981; 59:623-30. (Pubitemid 12013485)
21. Thai KT, Phuong HL, Thanh Nga TT, et al. Clinical, epidemiological and virological features of Dengue virus infections in Vietnamese patients presenting to primary care facilities with acute undifferentiated fever. J Infect 2010; 60:229-37.
22. Cardosa MJ. Dengue virus isolation by antibody dependent enhancement in macrophages. Lancet 1987; I1:193-94. (Pubitemid 17008194)
23. Zamree I, Drakes N, Rohani A, Lee HL. Sensitivity of Aedes albopictus C6/36 cells line for the detection and infectivity titration of dengue virus. Trop Biomed 2005; 22:217-19.
24. Wang WK, Chao DY, Kao CL, et al. High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: Implications for pathogenesis. Virology 2003; 305:330-8.